Payment overview · 2025
General Payments
$59.76
4 reported records · 1 companies
Healthcare provider profile · identity verified
Patrick H. Garrett, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · PALM COAST, FL · NPI 1821037979
Verified facts
What the public records show
CMS Open Payments records show Patrick H. Garrett, M.D. received $59.76 in general payments during 2025 across 4 reported records.
Novo Nordisk Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Wegovy.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 245 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Rybelsus by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Tresiba as an associated drug or biological on 415 records involving 264 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Tresiba by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Wegovy as an associated drug or biological on 183056 records involving 75256 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Wegovy by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $59.76 | 100.0% | 4 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $59.76 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $59.76 | 4 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Wegovy wegovy |
2025 | Wegovy | 2024 | 11 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
245 | 65 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Tresiba open payments reported associated product |
CMS Open Payments — General Payments 415 supporting records · 264 recipient NPIs · example record 1188130328 |
Tresiba · 2024 Exact normalized brand match · 1 Part D row |
18 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Wegovy open payments reported associated product |
CMS Open Payments — General Payments 183056 supporting records · 75256 recipient NPIs · example record 1188130070 |
Wegovy · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 3086 | 951 |
| Amlodipine Besylate | Amlodipine Besylate | 1691 | 518 |
| Lisinopril | Lisinopril | 1298 | 390 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1253 | 362 |
| Metformin Hcl | Metformin Hcl | 1011 | 297 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 974 | 320 |
| Losartan Potassium | Losartan Potassium | 963 | 293 |
| Omeprazole | Omeprazole | 913 | 306 |
| Tamsulosin Hcl | Tamsulosin Hcl | 868 | 308 |
| Gabapentin | Gabapentin | 747 | 309 |
| Sertraline Hcl | Sertraline Hcl | 734 | 252 |
| Trazodone Hcl | Trazodone Hcl | 715 | 246 |
| Prednisone | Prednisone | 628 | 438 |
| Baclofen | Baclofen | 617 | 229 |
| Metoprolol Succinate | Metoprolol Succinate | 617 | 199 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 573 | 232 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 568 | 448 |
| Hydrochlorothiazide | Hydrochlorothiazide | 522 | 162 |
| Glimepiride | Glimepiride | 484 | 149 |
| Finasteride | Finasteride | 470 | 162 |
| Pantoprazole Sodium | Pantoprazole Sodium | 462 | 157 |
| Clonazepam | Clonazepam | 439 | 94 |
| Tramadol Hcl | Tramadol Hcl | 426 | 115 |
| Metoprolol Tartrate | Metoprolol Tartrate | 419 | 178 |
| Bupropion Xl | Bupropion Hcl | 386 | 149 |
| Buspirone Hcl | Buspirone Hcl | 373 | 140 |
| Simvastatin | Simvastatin | 373 | 102 |
| Montelukast Sodium | Montelukast Sodium | 371 | 135 |
| Furosemide | Furosemide | 369 | 131 |
| Eliquis | Apixaban | 366 | 96 |
| Allopurinol | Allopurinol | 343 | 108 |
| Duloxetine Hcl | Duloxetine Hcl | 334 | 113 |
| Pravastatin Sodium | Pravastatin Sodium | 315 | 103 |
| Zolpidem Tartrate | Zolpidem Tartrate | 314 | 62 |
| Doxazosin Mesylate | Doxazosin Mesylate | 301 | 104 |
| Ezetimibe | Ezetimibe | 279 | 101 |
| Carvedilol | Carvedilol | 276 | 87 |
| Famotidine | Famotidine | 274 | 101 |
| Meloxicam | Meloxicam | 255 | 102 |
| Ipratropium Bromide | Ipratropium Bromide | 252 | 121 |
| Clopidogrel | Clopidogrel Bisulfate | 246 | 82 |
| Ozempic | Semaglutide | 245 | 65 |
| Doxycycline Hyclate | Doxycycline Hyclate | 244 | 184 |
| Fluoxetine Hcl | Fluoxetine Hcl | 238 | 82 |
| Lovastatin | Lovastatin | 219 | 66 |
| Pioglitazone Hcl | Pioglitazone Hcl | 206 | 70 |
| Atenolol | Atenolol | 196 | 54 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 195 | 109 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 184 | 156 |
| Fluticasone Propionate | Fluticasone Propionate | 180 | 64 |
| Ketoconazole | Ketoconazole | 177 | 83 |
| Dicyclomine Hcl | Dicyclomine Hcl | 171 | 60 |
| Synthroid | Levothyroxine Sodium | 167 | 51 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 166 | 46 |
| Ondansetron Odt | Ondansetron | 163 | 73 |
| Xarelto | Rivaroxaban | 162 | 42 |
| Donepezil Hcl | Donepezil Hcl | 160 | 58 |
| Azelastine Hcl | Azelastine Hcl | 154 | 79 |
| Pregabalin | Pregabalin | 154 | 54 |
| Citalopram Hbr | Citalopram Hydrobromide | 151 | 47 |
| Torsemide | Torsemide | 150 | 73 |
| Valacyclovir | Valacyclovir Hcl | 148 | 66 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 145 | 57 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 141 | 40 |
| Solifenacin Succinate | Solifenacin Succinate | 137 | 47 |
| Fenofibrate | Fenofibrate | 136 | 39 |
| Cephalexin | Cephalexin | 135 | 110 |
| Potassium Chloride | Potassium Chloride | 135 | 44 |
| Ropinirole Hcl | Ropinirole Hcl | 135 | 43 |
| Primidone | Primidone | 130 | 39 |
| Escitalopram Oxalate | Escitalopram Oxalate | 128 | 46 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 126 | 107 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 126 | 52 |
| Metformin Hcl Er | Metformin Hcl | 126 | 42 |
| Amitriptyline Hcl | Amitriptyline Hcl | 120 | 35 |
| Sildenafil Citrate | Sildenafil Citrate | 114 | 37 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 112 | 34 |
| Alendronate Sodium | Alendronate Sodium | 106 | 39 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 106 | 33 |
| Spironolactone | Spironolactone | 104 | 33 |
| Memantine Hcl | Memantine Hcl | 99 | 29 |
| Glipizide | Glipizide | 98 | 32 |
| Januvia | Sitagliptin Phosphate | 97 | 22 |
| Mirtazapine | Mirtazapine | 97 | 35 |
| Paroxetine Hcl | Paroxetine Hcl | 93 | 46 |
| Paxlovid | Nirmatrelvir/Ritonavir | 93 | 92 |
| Diclofenac Sodium | Diclofenac Sodium | 88 | 27 |
| Lamotrigine | Lamotrigine | 88 | 34 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 88 | 28 |
| Lorazepam | Lorazepam | 86 | 21 |
| Tizanidine Hcl | Tizanidine Hcl | 86 | 27 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 85 | 30 |
| Jardiance | Empagliflozin | 80 | 24 |
| Sumatriptan Succinate | Sumatriptan Succinate | 80 | 21 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 79 | 17 |
| Mounjaro | Tirzepatide | 79 | 18 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 78 | 39 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 78 | 25 |
| Aripiprazole | Aripiprazole | 75 | 25 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 75 | 23 |
| Fluconazole | Fluconazole | 73 | 54 |
| Nifedipine Er | Nifedipine | 73 | 24 |
| Diazepam | Diazepam | 71 | 23 |
| Celecoxib | Celecoxib | 70 | 25 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 70 | 26 |
| Levetiracetam | Levetiracetam | 70 | 21 |
| Topiramate | Topiramate | 69 | 27 |
| Fenofibrate | Fenofibrate Nanocrystallized | 65 | 22 |
| Mupirocin | Mupirocin | 64 | 47 |
| Propranolol Hcl | Propranolol Hcl | 62 | 23 |
| Ibuprofen | Ibuprofen | 60 | 23 |
| Levofloxacin | Levofloxacin | 60 | 56 |
| Valsartan | Valsartan | 60 | 21 |
| Breo Ellipta | Fluticasone/Vilanterol | 59 | 12 |
| Temazepam | Temazepam | 59 | suppressed |
| Ofloxacin | Ofloxacin | 55 | 48 |
| Irbesartan | Irbesartan | 54 | 14 |
| Warfarin Sodium | Warfarin Sodium | 54 | 15 |
| Benazepril Hcl | Benazepril Hcl | 53 | 18 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 53 | 19 |
| Ramipril | Ramipril | 53 | 16 |
| Quetiapine Fumarate | Quetiapine Fumarate | 52 | 18 |
| Clonidine Hcl | Clonidine Hcl | 49 | 14 |
| Oxybutynin Chloride | Oxybutynin Chloride | 49 | 20 |
| Clobetasol Propionate | Clobetasol Propionate | 48 | 19 |
| Dilt-Xr | Diltiazem Hcl | 47 | 16 |
| Tresiba Flextouch U-100 | Insulin Degludec | 46 | 15 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 45 | 16 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 45 | 15 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 45 | 13 |
| Tadalafil | Tadalafil | 45 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 44 | 24 |
| Farxiga | Dapagliflozin Propanediol | 44 | 14 |
| Estradiol | Estradiol | 43 | 21 |
| Nystatin | Nystatin | 43 | 23 |
| Meclizine Hcl | Meclizine Hcl | 42 | 38 |
| Methocarbamol | Methocarbamol | 42 | 14 |
| Telmisartan | Telmisartan | 42 | 11 |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 41 | 14 |
| Enalapril Maleate | Enalapril Maleate | 40 | suppressed |
| Hydrocortisone | Hydrocortisone | 40 | 27 |
| Naltrexone Hcl | Naltrexone Hcl | 40 | 36 |
| Myrbetriq | Mirabegron | 38 | 15 |
| Ventolin Hfa | Albuterol Sulfate | 38 | 18 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 36 | 17 |
| Nitroglycerin | Nitroglycerin | 36 | 23 |
| Colchicine | Colchicine | 34 | 16 |
| Amiodarone Hcl | Amiodarone Hcl | 33 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 33 | suppressed |
| Entresto | Sacubitril/Valsartan | 32 | suppressed |
| Glipizide Er | Glipizide | 32 | suppressed |
| Amoxicillin | Amoxicillin | 31 | 15 |
| Armour Thyroid | Thyroid,pork | 31 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 31 | 14 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 31 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 30 | 12 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 30 | 12 |
| Gemfibrozil | Gemfibrozil | 30 | suppressed |
| Lidocaine | Lidocaine | 29 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 29 | 23 |
| Silodosin | Silodosin | 29 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 29 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 28 | 11 |
| Verapamil Er | Verapamil Hcl | 28 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 27 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 27 | 12 |
| Brilinta | Ticagrelor | 26 | suppressed |
| Sucralfate | Sucralfate | 26 | 25 |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 25 | 20 |
| Symbicort | Budesonide/Formoterol Fumarate | 25 | suppressed |
| Bumetanide | Bumetanide | 24 | suppressed |
| Chlorthalidone | Chlorthalidone | 24 | suppressed |
| Eszopiclone | Eszopiclone | 24 | suppressed |
| Ibu | Ibuprofen | 24 | suppressed |
| Methimazole | Methimazole | 24 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 24 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 23 | 11 |
| Incruse Ellipta | Umeclidinium Bromide | 23 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 23 | 11 |
| Prazosin Hcl | Prazosin Hcl | 23 | suppressed |
| Lactulose | Lactulose | 22 | 20 |
| Midodrine Hcl | Midodrine Hcl | 22 | suppressed |
| Ramelteon | Ramelteon | 22 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 22 | suppressed |
| Acyclovir | Acyclovir | 21 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 21 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 21 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 21 | suppressed |
| Naproxen | Naproxen | 21 | 11 |
| Novolog | Insulin Aspart | 21 | suppressed |
| Trulicity | Dulaglutide | 21 | suppressed |
| Jantoven | Warfarin Sodium | 20 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 20 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 20 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 20 | 12 |
| Liothyronine Sodium | Liothyronine Sodium | 19 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 19 | 14 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 19 | suppressed |
| Penicillin V Potassium | Penicillin V Potassium | 19 | 19 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 19 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 18 | suppressed |
| Dutasteride | Dutasteride | 18 | suppressed |
| Metronidazole | Metronidazole | 18 | 16 |
| Tresiba | Insulin Degludec | 18 | suppressed |
| Zolmitriptan | Zolmitriptan | 18 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 17 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 17 | suppressed |
| Novolog Flexpen | Insulin Aspart | 17 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 17 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 17 | suppressed |
| Digoxin | Digoxin | 16 | suppressed |
| Euthyrox | Levothyroxine Sodium | 16 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 16 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 16 | suppressed |
| Rybelsus | Semaglutide | 16 | suppressed |
| Tacrolimus | Tacrolimus | 16 | 15 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 15 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 15 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 15 | suppressed |
| Indapamide | Indapamide | 15 | suppressed |
| Lansoprazole | Lansoprazole | 15 | suppressed |
| Paxlovid (Eua) | Nirmatrelvir/Ritonavir | 15 | 15 |
| Ranolazine Er | Ranolazine | 15 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 14 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 14 | suppressed |
| Droplet Insulin Syringe | Syringe And Needle,insulin,1ml | 14 | suppressed |
| Novolin N Flexpen | Insulin Nph Human Isophane | 14 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 14 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 14 | 12 |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Briviact | Brivaracetam | 13 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 13 | 12 |
| Doxepin Hcl | Doxepin Hcl | 13 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Felodipine Er | Felodipine | 13 | suppressed |
| Levemir | Insulin Detemir | 13 | suppressed |
| Lipitor | Atorvastatin Calcium | 13 | suppressed |
| Repatha Syringe | Evolocumab | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Klor-Con 10 | Potassium Chloride | 12 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 12 | 12 |
| Norvasc | Amlodipine Besylate | 12 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 12 | suppressed |
| Repatha Sureclick | Evolocumab | 12 | suppressed |
| Steglatro | Ertugliflozin Pidolate | 12 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 11 | suppressed |
| Epinephrine | Epinephrine | 11 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 11 | suppressed |
| Metolazone | Metolazone | 11 | suppressed |
| Movantik | Naloxegol Oxalate | 11 | suppressed |
| Olanzapine | Olanzapine | 11 | suppressed |
| Pentoxifylline | Pentoxifylline | 11 | suppressed |
| Sotalol | Sotalol Hcl | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
| Wegovy | Semaglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $59.76 · 4 records | Novo Nordisk Inc | Wegovy | 4 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Wegovy play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error